E. Nikaï

623 total citations
15 papers, 415 citations indexed

About

E. Nikaï is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, E. Nikaï has authored 15 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Dermatology and 7 papers in Rheumatology. Recurrent topics in E. Nikaï's work include Psoriasis: Treatment and Pathogenesis (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Dermatology and Skin Diseases (7 papers). E. Nikaï is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Dermatology and Skin Diseases (7 papers). E. Nikaï collaborates with scholars based in United States, United Kingdom and Germany. E. Nikaï's co-authors include Emily Edson‐Heredia, Vibeke Strand, Ronald van Vollenhoven, Gerd R Burmester, G. Coteur, Philip J. Mease, Gil Yosipovitch, Alexa B. Kimball, Baojin Zhu and Yvonne Norton and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

E. Nikaï

14 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Nikaï United States	8	238	210	143	92	74	15	415
Joanne Fuiman United States	6	341 1.4×	442 2.1×	138 1.0×	247 2.7×	25 0.3×	12	556
Jeffrey M. Sobell United States	12	71 0.3×	256 1.2×	349 2.4×	36 0.4×	50 0.7×	26	524
Vanessa Venning United Kingdom	7	130 0.5×	139 0.7×	97 0.7×	27 0.3×	138 1.9×	10	294
Patrick Dominguez United States	9	178 0.7×	276 1.3×	91 0.6×	75 0.8×	23 0.3×	9	414
Giorgia Grosso Sweden	9	139 0.6×	205 1.0×	59 0.4×	46 0.5×	19 0.3×	19	330
Magda D’Agostino Italy	8	123 0.5×	224 1.1×	87 0.6×	49 0.5×	30 0.4×	9	337
Fan Emily Yang United States	8	123 0.5×	177 0.8×	397 2.8×	18 0.2×	62 0.8×	19	491
Moetaza M. Soliman Egypt	9	281 1.2×	176 0.8×	69 0.5×	126 1.4×	53 0.7×	24	449
Johan K. Wallman Sweden	14	381 1.6×	202 1.0×	15 0.1×	123 1.3×	42 0.6×	45	454

Countries citing papers authored by E. Nikaï

Since Specialization

Citations

This map shows the geographic impact of E. Nikaï's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Nikaï with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Nikaï more than expected).

Fields of papers citing papers by E. Nikaï

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Nikaï. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Nikaï. The network helps show where E. Nikaï may publish in the future.

Co-authorship network of co-authors of E. Nikaï

This figure shows the co-authorship network connecting the top 25 collaborators of E. Nikaï. A scholar is included among the top collaborators of E. Nikaï based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Nikaï. E. Nikaï is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Langley, Richard G., Kristian Reich, Vibeke Strand, et al.. (2019). Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis. Quality of Life Research. 29(2). 369–380. 4 indexed citations

Armstrong, April W., Emily Edson‐Heredia, Baojin Zhu, et al.. (2017). Burden of Psoriasis as Reported in a Cross-Sectional Study: Association of Psoriasis Severity with Health-Related Quality of Life, Depression, and Work Productivity. 2(4). 106–112. 3 indexed citations

Foster, Shonda A., Baojin Zhu, Jiaying Guo, et al.. (2016). Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis. Journal of Managed Care & Specialty Pharmacy. 22(4). 396–405. 22 indexed citations

Kimball, Alexa B., Thomas A. Luger, Alice B. Gottlieb, et al.. (2016). Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials. Journal of the American Academy of Dermatology. 75(6). 1156–1161. 36 indexed citations

Kimball, Alexa B., April N. Naegeli, Emily Edson‐Heredia, et al.. (2016). Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis. British Journal of Dermatology. 175(1). 157–162. 76 indexed citations

Armstrong, April W., Charles Lynde, Sandy McBride, et al.. (2016). Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis. JAMA Dermatology. 152(6). 661–661. 45 indexed citations

Edson‐Heredia, Emily, et al.. (2015). The Value of Achieving Complete or Near Complete Resolution of Psoriasis. Value in Health. 18(7). A427–A427. 1 indexed citations

Gordon, Caroline, David Isenberg, Kirsten Lerstrøm, et al.. (2013). The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey. Lara D. Veeken. 52(12). 2292–2301. 77 indexed citations

Strand, Vibeke, et al.. (2013). Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey. Lupus. 22(8). 819–826. 20 indexed citations

10.

Strand, Vibeke, Kenneth Kalunian, Daniel J. Wallace, et al.. (2012). AB0633 Epratuzumab-treated SLE patients report improvements in health-related quality of life: Interim results from a us open-label extension study. Annals of the Rheumatic Diseases. 71. 675–675. 1 indexed citations

11.

Schneider, Matthias, et al.. (2012). SAT0196 An assessment of impairment of productivity among SLE patients. Annals of the Rheumatic Diseases. 71. 538–538. 1 indexed citations

12.

Lerstrøm, Kirsten, et al.. (2011). PSY46 DISEASE SYMPTOMS, TREATMENT SATISFACTION, AND COPING STRATEGIES IN PATIENTS WITH LUPUS. Value in Health. 14(3). A67–A67.

13.

Schneider, Matthias, Caroline Gordon, Kirsten Lerstrøm, et al.. (2011). PSY45 Impact of Lupus on Career Choices and Work productivity in Five European Countries: Results from the Lupus European Online (Leo) Survey. Value in Health. 14(7). A418–A418. 1 indexed citations

14.

Strand, Vibeke, Josef S Smolen, Ronald van Vollenhoven, et al.. (2011). Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial. Annals of the Rheumatic Diseases. 70(6). 996–1002. 54 indexed citations

15.

Strand, Vibeke, Philip J. Mease, Gerd R Burmester, et al.. (2009). Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial. Arthritis Research & Therapy. 11(6). R170–R170. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact